Literature DB >> 381177

The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures.

B S Kelly, J G Levy, L Sikora.   

Abstract

The solid phase enzyme linked immunosorbent assay (ELISA) has been used to quantify anti-keyhole limpet haemocyanin (anti-KLH) antibody in the serum of KLH-immune C57Bl/6 mice. When spleen cells from immune mice were cultured overnight in ELISA microtitre wells to which KLH had been adsorbed it was found that easily quantifiable amounts of anti-KLH antibody were synthesized and were detectable. It was found further that spleen cells from KLH-primed mice, when cultured in vitro in the presence of KLH, transferred to KLH-labelled ELISA plates, and cultured overnight, also produced detectable levels of antibody. Levels of antibody were detectable only after 4 and 5 days of in vitro stimulation. A comparison was made between detectable numbers of plaque forming cells to sheep red blood cells (SRBC) in SRBC primed CBA mice and levels of antibody detected by the ELISA procedure. It was found that the sensitivities of the two tests were comparable. The applications of this technique to the study of in vitro antibody synthesis using soluble antigens are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381177      PMCID: PMC1457304     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  7 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  The enzyme-linked immunosorbent assay (ELISA): a measure of antibody concentration or affinity.

Authors:  J E Butler; T L Feldbush; P L McGivern; N Stewart
Journal:  Immunochemistry       Date:  1978-02

3.  A solid phase enzyme-linked immunosurbent assay (ELISA) for the demonstration of antibodies against denatured, single-stranded DNA in patient sera.

Authors:  M Gripenberg; E Linder; P Kurki; E Engvall
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

5.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

6.  Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.

Authors:  J G Levy; R McMaster; B Kelly; R B Whitney; D G Kilburn
Journal:  Immunology       Date:  1977-04       Impact factor: 7.397

7.  Isolation of pure normal IgG 1 from mouse serum.

Authors:  S Dissanayake; F C Hay
Journal:  Immunochemistry       Date:  1975-01
  7 in total
  23 in total

1.  Characterization of tumor necrosis factor-deficient mice.

Authors:  M W Marino; A Dunn; D Grail; M Inglese; Y Noguchi; E Richards; A Jungbluth; H Wada; M Moore; B Williamson; S Basu; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Contribution of the spleen, lymph nodes and bone marrow to the antibody response in collagen-induced arthritis in the rat.

Authors:  J Rahman; N A Staines
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

3.  Correction or transfer of immunodeficiency due to TNF-LT alpha deletion by bone marrow transplantation.

Authors:  M Müller; H P Eugster; M Le Hir; A Shakhov; F Di Padova; C Maurer; V F Quesniaux; B Ryffel
Journal:  Mol Med       Date:  1996-03       Impact factor: 6.354

4.  Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense.

Authors:  Min Wei; Reiko Shinkura; Yasuko Doi; Mikako Maruya; Sidonia Fagarasan; Tasuku Honjo
Journal:  Nat Immunol       Date:  2011-01-23       Impact factor: 25.606

5.  B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters.

Authors:  H Mizuma; S Litwin; S Zolla-Pazner
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

6.  Stimulation of human blood lymphocyte by different polyclonal B cell activators of bacterial and plant origin: production of IgM, IgG and IgA estimated by the ELISA method.

Authors:  H Tlaskalová-Hogenová; J Bártová; L Mrklas; P Mancal; Z Broukal; R Barot-Ciorbaru; M Novák; M Hanikýrová
Journal:  Folia Microbiol (Praha)       Date:  1985       Impact factor: 2.099

7.  Apurinic/apyrimidinic endonuclease 2 regulates the expansion of germinal centers by protecting against activation-induced cytidine deaminase-independent DNA damage in B cells.

Authors:  Jeroen E J Guikema; Erin K Linehan; Nada Esa; Daisuke Tsuchimoto; Yusaku Nakabeppu; Robert T Woodland; Carol E Schrader
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

8.  Detection of membrane-bound and soluble antigens by magnetic levitation.

Authors:  Mikkel Schou Andersen; Emily Howard; Shulin Lu; Matthew Richard; Mark Gregory; Gordon Ogembo; Ofer Mazor; Pavel Gorelik; Nathan I Shapiro; Anish V Sharda; Ionita Ghiran
Journal:  Lab Chip       Date:  2017-10-11       Impact factor: 6.799

9.  Treatment of refractory chronic idiopathic thrombocytopenic purpura with high dose intravenous immunoglobulin.

Authors:  E Seifried; G Pindur; H Stötter; M Wiesneth; H Rasche; H Heimpel
Journal:  Blut       Date:  1984-06

10.  Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor.

Authors:  T Maier; J G Levy
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.